Bergenfelz Anders, Bladström Anna, Their Mark, Nordenström Erik, Valdemarsson Stig, Westerdahl Johan
Department of Surgery, Lund University Hospital, 221 85 Lund, Sweden.
World J Surg. 2007 Jul;31(7):1393-400; discussion 1401-2. doi: 10.1007/s00268-007-9091-6.
Primary hyperparathyroidism (pHPT) is associated with an increased mortality attributable to cardiovascular disease (CVD), suggested to be alleviated by surgery. The exact mechanism of the beneficial influence of parathyroidectomy on survival is unknown. Furthermore, studies suggest that there is no increased mortality compared to the mortality rate in the general population during recent years. This study therefore investigated relative survival (RS), as well overall mortality associated with the clinical and biochemical variables in patients undergoing operation for sporadic pHPT. Furthermore, the influence of surgery on biochemical variables associated with pHPT was analyzed.
A group of 323 patients with sporadic pHPT operated between September 1989 and July 2003 were followed from surgery over a 10-year period. The median and mean follow-up time was 69 and 70 months, respectively (range: 1-120 months). Relative survival (RS) was calculated, and the impact of clinical and biochemical variables on overall death were evaluated.
Postoperatively, serum levels of triglycerides and uric acid decreased. Glucose levels and glomerular filtration rate remained unchanged. A decreased RS was evident during the latter part of the 10 year follow-up period. In the multivariate Cox-analysis, diabetes mellitus (hazard ratio [HR] = 2.8, 95%; confidence interval [CI] 1.2-6.7), and the combination of an increased level of serum uric acid and cardiovascular disease (CVD) (HR = 8.6, 95%; CI 1.5-49.7) was associated with a higher mortality. The increased risk of death was evident for patients with persistently increased levels of uric acid postoperatively (HR = 4.8, 95%; CI = 1.4-16.01).
Patients undergoing operation for pHPT had a decreased RS during a 10-year follow-up compared to the general population. This decrease in RS is associated with diabetes mellitus and increased levels of uric acid pre-and postoperatively.
原发性甲状旁腺功能亢进症(pHPT)与心血管疾病(CVD)导致的死亡率增加相关,手术有望缓解这种情况。甲状旁腺切除对生存率产生有益影响的确切机制尚不清楚。此外,研究表明,与近年来普通人群的死亡率相比,该疾病患者的死亡率并未增加。因此,本研究调查了散发性pHPT手术患者的相对生存率(RS)以及与临床和生化变量相关的总体死亡率。此外,还分析了手术对与pHPT相关的生化变量的影响。
对1989年9月至2003年7月间接受手术的323例散发性pHPT患者进行了为期10年的随访。中位随访时间和平均随访时间分别为69个月和70个月(范围:1 - 120个月)。计算相对生存率(RS),并评估临床和生化变量对总体死亡的影响。
术后,血清甘油三酯和尿酸水平下降。血糖水平和肾小球滤过率保持不变。在10年随访期的后半段,相对生存率明显下降。在多因素Cox分析中,糖尿病(风险比[HR] = 2.8,95%;置信区间[CI] 1.2 - 6.7)以及血清尿酸水平升高与心血管疾病(CVD)并存(HR = 8.6,95%;CI 1.5 - 49.7)与较高的死亡率相关。术后尿酸水平持续升高的患者死亡风险增加明显(HR = 4.8,95%;CI = 1.4 - 16.01)。
与普通人群相比,接受pHPT手术的患者在10年随访期间相对生存率降低。这种相对生存率的降低与糖尿病以及术前和术后尿酸水平升高有关。